Search Within

Hematologic Malignancies Service

Formats
  1. Journal Article (350)
  2. Meeting Abstract (237)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Correspondence (1)
Groups
  1. Pediatrics, Department of (614)
  2. Center for Hematologic Malignancies (557)
  3. Pediatric Leukemia (457)
  4. GSK Faculty (222)
  5. Tow Center for Developmental Oncology (TCDO) (208)
  6. Department of Medicine (150)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (161)
  3. Tanya Trippett (126)
  4. Alex Kentsis (104)
  5. Christopher Forlenza (51)
  6. Marc Ladanyi (45)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (130)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Clinical Cancer Research (16)

More Publications

Publishers
  1. American Society of Hematology (139)
  2. American Society of Clinical Oncology (69)
  3. American Association for Cancer Research (57)
  4. Wiley Periodicals, Inc (57)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (31)

More Publishers

Results (614)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study
    Journal Article

    Abramson, D. H.; Mandelker, D. L.; Brannon, A. R.; Dunkel, I. J.; Benayed, R.; Berger, M. F.; Arcila, M. E.; Ladanyi, M.; Friedman, D. N.; Jayakumaran, G.; more...
    PLoS ONE (2023)

    Fulltext@MSK | Save
  • Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia
    Journal Article

    Cole, P. D.; Kim, S. Y.; Li, Y.; Schembri, A.; Kelly, K. M.; Sulis, M. L.; Vrooman, L.; Welch, J. J. G.; Ramjan, S.; Silverman, L. B.; more...
    Supportive Care in Cancer (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A human pluripotent stem cell derived differentiation model for the study of normal and transformed sympatho-adrenal progenitors
    Meeting Abstract

    Van Haver, S.; Fan, Y.; Van Loocke, W.; De Preter, K.; Kentsis, A.; Studer, L.; Roberts, S.; Speleman, F.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The AP-1/ETS transcription factor network regulates stem cell quiescence and chemotherapy resistance in acute myeloid leukemia
    Meeting Abstract

    Takao, S.; Morell, V.; Brown, F. C.; Koche, R.; Kentsis, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Antigen directed therapy pre-transplant confers superior post-transplant survival outcome compared to conventional chemotherapy in pediatric patients with relapsed and refractory B-ALL
    Meeting Abstract

    Stiefel, J.; Flower, A. M.; Botwinick, M.; Ford, M.; Foti, A.; Gandhi, M.; Slovin, J.; Smilow, E.; Bowers, A.; Karpel, H.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlation of minimal residual disease (MRD) at the end of induction (EOI) and event free survival (EFS) in T-cell lymphoblastic lymphoma (T-LL), a report from the children's oncology group (COG) trial AALL1231
    Meeting Abstract

    Hayashi, R. J.; Hermiston, M. L.; Teachey, D. T.; Devidas, M.; Wood, B. L.; Chen, Z.; Annett, R. D.; Asselin, B. L.; August, K. J.; Cho, S. Y.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Unmatched whole-genome sequencing as a clinical tool for hematological neoplasms with significant utility in cases with tumor-in-normal contamination
    Meeting Abstract

    GutieĢrrez-Abril, J.; Leongamornlert, D.; Shukla, N. N.; Sulis, M. L.; Zhou, Y.; Levine, M. F.; Barretta, E.; Lee, S.; Arango-Ossa, J. E.; Gundem, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: Updated results of a phase (Ph) 1 study
    Meeting Abstract

    Issa, G. C.; Aldoss, I.; DiPersio, J. F.; Cuglievan, B.; Stone, R. M.; Arellano, M. L.; Thirman, M. J.; Patel, M. R.; Dickens, D.; Shenoy, S.; more...
    Blood (2022)

    Fulltext@MSK | Save